United States Solid Tumors Drugs Market Report 2016

United States Solid Tumors Drugs Market Report 2016

1 Solid Tumors Drugs Overview

1.1 Product Overview and Scope of Solid Tumors Drugs

1.2 Classification of Solid Tumors Drugs

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Solid Tumors Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Solid Tumors Drugs (2011-2021)

1.4.1 United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)

1.4.2 United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

2 United States Solid Tumors Drugs Competition by Manufacturers

2.1 United States Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Solid Tumors Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Solid Tumors Drugs Average Price by Manufactures (2015 and 2016)

2.4 Solid Tumors Drugs Market Competitive Situation and Trends

2.4.1 Solid Tumors Drugs Market Concentration Rate

2.4.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Solid Tumors Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Solid Tumors Drugs Sales and Market Share by Type (2011-2016)

3.2 United States Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)

3.3 United States Solid Tumors Drugs Price by Type (2011-2016)

3.4 United States Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)

4 United States Solid Tumors Drugs Sales (Volume) by Application (2011-2016)

4.1 United States Solid Tumors Drugs Sales and Market Share by Application (2011-2016)

4.2 United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Solid Tumors Drugs Manufacturers Profiles/Analysis

5.1 Hoffmann-La Roche

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Solid Tumors Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Novartis

5.2.2 Solid Tumors Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Celgene

5.3.2 Solid Tumors Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Johnson & Johnson

5.4.2 Solid Tumors Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Pfizer

5.5.2 Solid Tumors Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 BMS

5.6.2 Solid Tumors Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 AbbVie

5.7.2 Solid Tumors Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 AbGenomics

5.8.2 Solid Tumors Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 ADC Therapeutics

5.9.2 Solid Tumors Drugs Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 TG Therapeutics

5.10.2 Solid Tumors Drugs Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 TG Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Polaris Pharmaceuticals

5.12 Immunogen

5.13 CTI BioPharma

5.14 Chugai Pharmaceutical

5.15 NewLink Genetics

6 Solid Tumors Drugs Manufacturing Cost Analysis

6.1 Solid Tumors Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Solid Tumors Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Solid Tumors Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Solid Tumors Drugs Market Forecast (2016-2021)

10.1 United States Solid Tumors Drugs Sales, Revenue Forecast (2016-2021)

10.2 United States Solid Tumors Drugs Sales Forecast by Type (2016-2021)

10.3 United States Solid Tumors Drugs Sales Forecast by Application (2016-2021)

10.4 Solid Tumors Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Solid Tumors Drugs

Table Classification of Solid Tumors Drugs

Figure United States Sales Market Share of Solid Tumors Drugs by Type in 2015

Table Application of Solid Tumors Drugs

Figure United States Sales Market Share of Solid Tumors Drugs by Application in 2015

Figure United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)

Figure United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Table United States Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers

Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers

Table United States Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Solid Tumors Drugs Revenue Share by Manufacturers

Table 2016 United States Solid Tumors Drugs Revenue Share by Manufacturers

Table United States Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015

Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers

Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers

Table United States Solid Tumors Drugs Sales by Type (2011-2016)

Table United States Solid Tumors Drugs Sales Share by Type (2011-2016)

Figure United States Solid Tumors Drugs Sales Market Share by Type in 2015

Table United States Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)

Table United States Solid Tumors Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Solid Tumors Drugs by Type (2011-2016)

Table United States Solid Tumors Drugs Price by Type (2011-2016)

Figure United States Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)

Table United States Solid Tumors Drugs Sales by Application (2011-2016)

Table United States Solid Tumors Drugs Sales Market Share by Application (2011-2016)

Figure United States Solid Tumors Drugs Sales Market Share by Application in 2015

Table United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)

Figure United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)

Table Hoffmann-La Roche Basic Information List

Table Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hoffmann-La Roche Solid Tumors Drugs Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Solid Tumors Drugs Sales Market Share (2011-2016)

Table Celgene Basic Information List

Table Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Solid Tumors Drugs Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Solid Tumors Drugs Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Solid Tumors Drugs Sales Market Share (2011-2016)

Table BMS Basic Information List

Table BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table BMS Solid Tumors Drugs Sales Market Share (2011-2016)

Table AbbVie Basic Information List

Table AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbbVie Solid Tumors Drugs Sales Market Share (2011-2016)

Table AbGenomics Basic Information List

Table AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbGenomics Solid Tumors Drugs Sales Market Share (2011-2016)

Table ADC Therapeutics Basic Information List

Table ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table ADC Therapeutics Solid Tumors Drugs Sales Market Share (2011-2016)

Table TG Therapeutics Basic Information List

Table TG Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table TG Therapeutics Solid Tumors Drugs Sales Market Share (2011-2016)

Table Polaris Pharmaceuticals Basic Information List

Table Polaris Pharmaceuticals Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Polaris Pharmaceuticals Solid Tumors Drugs Sales Market Share (2011-2016)

Table Immunogen Basic Information List

Table Immunogen Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Immunogen Solid Tumors Drugs Sales Market Share (2011-2016)

Table CTI BioPharma Basic Information List

Table CTI BioPharma Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table CTI BioPharma Solid Tumors Drugs Sales Market Share (2011-2016)

Table Chugai Pharmaceutical Basic Information List

Table Chugai Pharmaceutical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chugai Pharmaceutical Solid Tumors Drugs Sales Market Share (2011-2016)

Table NewLink Genetics Basic Information List

Table NewLink Genetics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table NewLink Genetics Solid Tumors Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Solid Tumors Drugs

Figure Manufacturing Process Analysis of Solid Tumors Drugs

Figure Solid Tumors Drugs Industrial Chain Analysis

Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015

Table Major Buyers of Solid Tumors Drugs

Table Distributors/Traders List

Figure United States Solid Tumors Drugs Production and Growth Rate Forecast (2016-2021)

Figure United States Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Table United States Solid Tumors Drugs Production Forecast by Type (2016-2021)

Table United States Solid Tumors Drugs Consumption Forecast by Application (2016-2021)